Diatherix
Dennis Grimaud serves as the Chairman and CEO of Diatherix Laboratories, Inc., and previously held the position of CEO at Genaco Biomedical Products, Inc. with extensive experience in leadership roles within the biomedical industry.
Diatherix
A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCR™. Eurofins Diatherix distinctions: - Delivers one-day results - Identifies bacteria regardless of recent antibiotic use - Offers simplicity of single-sample collection - Identifies difficult-to-culture pathogens - Yields a high level of sensitivity and specificity